Register for your FREE account now and join the thousands of healthcare professionals who have depended on us for over 26 years for accurate, concise, and timely drug information.

Keep me logged in Forgot your password?

Please wait...

Please wait...

Immune System Resource Center

Welcome to the MPR Immune System Resource Center, where you will find everything you need to make informed clinical decisions.

Drug Monographs
Click on the subcategory below to find drug monographs for that particular area.

News

BioThrax Administration Schedule Changed

The FDA has approved a change to the administration schedule of BioThrax (anthrax vaccine adsorbed) to a three-dose primary series of IM injections at 0, 1, and 6 months.
 

Post-SES Implantation, Statins Prevent Late Revascularization

For patients who undergo sirolimus-eluting stent (SES) implantation, use of statin therapy is associated with a reduced risk of late target lesion revascularization (TLR).
 

Rituximab Little Use in Resistant Idiopathic Nephrotic Syndrome

The anti-CD20 monoclonal antibody, rituximab, added to prednisone and calcineurin inhibitors, does not provide any additional benefit in terms of reduced proteinuria in the treatment of children with resistant idiopathic nephrotic syndrome (INS).
 

New Meningitis B Vaccine Strongly Immunogenic

A new meningococcus serogroup B vaccine is strongly immunogenic against multiple strains and well tolerated in healthy adolescents.
 

School Vaccination Requirements Up Coverage

Middle school entry vaccination requirements may increase coverage for adolescent vaccines, but education-only requirements do not appear to have an impact.
 

INDUSTRY SUPPORTED EDUCATION

New Drugs

BENLYSTA

3/31/2011

Pharmacological Class: Biologic (human IgG1gamma monoclonal antibody).
Active Ingredient(s): Belimumab 120mg/vial, 400mg/vial; pwd for IV infusion after recon­stitution and dilution.
Indication: Systemic lupus erythematosus, in adults with active, autoantibody-positive SLE on standard therapy.
 

ClinicalJobAdvisor

Loading...

More Jobs

© 2012 Haymarket Media, Inc.

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization.

Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions